Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
375 shares will do it. That’s worth a good laugh. That was childish of him to buy like that. Tells you his character as CEO.
Problem is this company has NEVER done anything early regarding trials.
$1.20’s soon. Market looks nasty and uncertainty is only growing.
Unfortunately China matters.
$1.20’s? At this pace. Very feasible.
Its in black and white on Fintel. Basp is the one stating Park West bought. Not I
The verbiage change and now the poster states something like reduce cognitive decline. The current drugs reduce cognitive decline. Lifestyle change can also slow cognitive decline.
The ultimate value has been inherently reduced by many.
Tutes are selling. Bottomline.
To deny the fact tutes have not been selling is more foolish.
Lake, perfect post. Thanks for scribing.
We go back to staples.
When gas is $4.00 bucks a gallon people buy cars and when gas is $2.00 it’s the SUV.
When excess capital in market we spend on wants and when market is tight we got back to staples.
It’s staple time and AVXL is not a staple.
Waiting for CEO and some board members to be fired. Waiting for additional dilution. Waiting for discrepancies in posters to be cleared up. Waiting for goal post to stop moving. As I stated months ago, this is dead money. No need to buy anymore at high prices.
Hope drug helps more than 6 people.
Will keep an eye as different MOA.
Hit $1.52 as I stated, low for the day was hit. I see some small buyers move in. Key world Small.
Low for the day coming up.
The case for trend following. This applies to anavex.
The Case For Trend-Following Over Buy And Hold https://seekingalpha.com/article/4229244
Buy today. Raja
If Park West is doing the buying, caveat emptor. As stated yesterday.
Lol. It went from over 20% just a few months ago down to 17.60%. 1500 shares
Urge everyone to go to fintel and review all of the selling.
Good bye.
Fintel 17.60% a week ago it was 18.05%.
Life Sciences Corp. (032797300)
President and CEO MISSLING CHRISTOPHER U
Industry Commercial Physical and Biological Research
Institutional Owners 63 (16 N-Q Owners)
Institutional Shares 8,200,457 - 17.60% (ex. N-Q)
Common Shares Outstanding 46,586,162 shares (as of 2018-09-30)
Institutional Value $ 25,849,000 USD
I was smart enough to sell @$2.80. If I buy those shares back tomorrow , who is ahead. I bought those shares @ $1.98.
Now overall I’m still down tens of thousands in this baby. Not bragging about that.
Agree on the park west. I wouldn’t compose a letter to investors on that news.
Blame him for investors losing confidence. Over promised and under delivered= failed SP. This stock has been trending down for years.
I hope the science prevails but company will continue to falter with old board members.
Imo the writing has been on the wall for a long time. When the CEO tried and tried to get ALZ trial in North America and it’s still not approved something is wrong. FDA is so liberal now.
The other indication FDA approved is softball.
Thanks. I agree 100%. Any realistic view on MB is not always a short.
Avxl has a lot more room to drop. Tute recently sold 460k shares. More will reduce exposure.
Maybe someone will buy 375 shares to pump.
Not you jones. Leave the firing to me. That’s my space.
Opportunity costs are real costs.
That’s why it is good to buy and sell stocks. We don’t marry investments we just date them.
Last I checked Fintel tutes were selling also. Down around 18%.
It’s the market. Investors around the world are getting cautious with good reason. Has nothing to do with Anavex.
Waste of time for two and a half of those three years. SOC approved after 28 week trial. Don’t need to run a trial beyond SOC.
CC didn’t move SP, tutes are selling and market is weak. Catalyst is a ways off, company keeps adding overhead, history of wasting cash with missed timelines. SP is going to keep trending in the same direction.
Kiss your money good bye.
Late stage of life is right. It’s going down like a jersey prostitute.
In the last month a purchased 5,000 more at an average near $6. So this is really painful knowing that 5k shares could have been 7k shares.
Is Aricept the same as Namenda/memantine? I was thinking the compounds were different and some of the folks in the placebo were taking Aricept.
I apologize in advance for not investigating.
A mixture. Lilly leaving BACE space but not ALZ.
https://www.biospace.com/article/eli-lilly-quietly-scraps-a-bace-program-for-alzheimer-s/